Angiodynamics (ANGO) Accumulated Depreciation & Amortization (2011 - 2025)

Angiodynamics (ANGO) has 15 years of Accumulated Depreciation & Amortization data on file, last reported at -$28.5 million in Q2 2025.

• For the quarter ending Q2 2025, Accumulated Depreciation & Amortization fell 139.29% year-over-year to -$28.5 million; the trailing twelve-month figure through May 2025 stood at -$28.5 million (down 139.29% YoY), and the FY2025 full-year result was -$28.5 million, down 139.29% from the prior year.
• Accumulated Depreciation & Amortization for Q2 2025 stood at -$28.5 million, down from $72.5 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $72.5 million in Q2 2024 and bottomed at -$28.5 million in Q2 2025.
• The 5-year median for Accumulated Depreciation & Amortization is $50.6 million (2022), against an average of $39.7 million.
• The widest annual swing landed in 2024, when Accumulated Depreciation & Amortization rose 23.94%; it then tumbled 139.29% in 2025.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $45.2 million in 2021, then grew by 11.99% to $50.6 million in 2022, then climbed by 15.73% to $58.5 million in 2023, then grew by 23.94% to $72.5 million in 2024, then sank by 139.29% to -$28.5 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at -$28.5 million (Q2 2025), $72.5 million (Q2 2024), and $58.5 million (Q2 2023), per Business Quant data.

Peer Comparison